{"symbol": "GBT", "companyName": "Global Blood Therapeutics Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.gbt.com", "description": "Global Blood Therapeutics Inc is a clinical-stage biopharmaceutical company in the United States. Its major focus lies on developing therapeutics for the treatment of blood-based disorders such as red blood cell sickling.", "CEO": "Ted W. Love", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}